Literature DB >> 8097974

Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum.

C Pu1, C V Vorhees.   

Abstract

In 60- and 80-day-old rats, TH-positive terminal depletion occurred simultaneously with increased glial fibrillary acid protein (GFAP)-containing astrocytes in the caudate-putamen nucleus following four 10 or 20 mg/kg methamphetamine treatments. At 40 days, astrocytes were increased without depletion of TH-positive terminals. At younger ages (20 days old) neither marker was altered. Processes leading to methamphetamine-induced gliosis and TH-positive terminal depletion may not be present in rats prior to 40 and 60 days, respectively. The data suggest that factors other than degenerated dopaminergic terminals, such as increased glutamate release and/or production of free radicals may be involved in triggering striatal gliosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097974     DOI: 10.1016/0165-3806(93)90201-k

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  42 in total

Review 1.  Differential effects of psychoactive drugs in adolescents and adults.

Authors:  Sari Izenwasser
Journal:  Crit Rev Neurobiol       Date:  2005

Review 2.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

Review 3.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 4.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

5.  Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.

Authors:  Trecia A Wouldes; Linda L Lagasse; Marilyn A Huestis; Sheri Dellagrotta; Lynne M Dansereau; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2014-02-22       Impact factor: 3.763

6.  Cockayne syndrome B protects against methamphetamine-enhanced oxidative DNA damage in murine fetal brain and postnatal neurodevelopmental deficits.

Authors:  Gordon P McCallum; Andrea W Wong; Peter G Wells
Journal:  Antioxid Redox Signal       Date:  2011-01-05       Impact factor: 8.401

7.  Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

8.  Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.

Authors:  David Pubill; Anna M Canudas; Mercè Pallàs; Antonio Camins; Jorge Camarasa; Elena Escubedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-09       Impact factor: 3.000

9.  Effect of amphetamine on the expression of the metabotropic glutamate receptor 5 mRNA in developing rat brain.

Authors:  M F Yu; W M Fu; H S Yin
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

10.  Toxic effect of methamphetamine on the retina of CD1 mice.

Authors:  Hong Lai; Huiyang Zeng; Cheng Zhang; Lin Wang; Mark O M Tso; Shenghan Lai
Journal:  Curr Eye Res       Date:  2009-09       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.